Position in FATE
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$120,887
+$62,543 QoQ
Shares Held
44,773
+26.6% QoQ
Ownership
0.038%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#3
of 7 holders
Holding Since
Jun 2021
7 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in FATE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Y-Intercept (Hong Kong) Ltd holds $205,108,253 across 117 Biotechnology names. FATE ranks #103 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
101,908 | $10,865,430 | |
| 2 | MRNA |
Moderna, Inc.
|
139,861 | $9,794,465 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
107,419 | $8,000,567 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
22,923 | $5,610,862 | |
| 5 | IONS |
Ionis Pharmaceuticals Inc
|
67,374 | $5,342,084 | |
| 6 | ADMA |
Adma Biologics, Inc.
|
573,581 | $4,800,872 | |
| 7 | UPB |
Upstream Bio, Inc.
|
693,555 | $4,799,400 | |
| 8 | NRIX |
Nurix Therapeutics, Inc.
|
192,434 | $4,668,448 |
All Filings in FATE
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $120,887 | 44,773 | Shares | Sole | 2026-07-14 | |
| 2024-12-31 | $58,344 | 35,360 | Shares | Sole | 2025-02-04 | |
| 2024-06-30 | $55,933 | 17,053 | Shares | Sole | 2024-08-14 | |
| 2023-09-30 | $202,879 | 95,698 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $155,090 | 32,582 | Shares | Sole | 2023-08-14 | |
| 2021-09-30 | $377,905 | 6,376 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $445,059 | 5,128 | Shares | Sole | 2021-08-26 | |
| No filing history on record for this holder in this stock. | ||||||